The U.S. Food and Drug Administration (FDA) has issued warnings to nine companies for selling 14 unapproved narcotic pain medicines as part of an ongoing effort to rid the market of drugs without proper approval. FDA officials said the widely used prescription medicines contained morphine, hydromorphone, or oxycodone. The companies--which include Boehringer Ingelheim's Roxane Inc unit, Covidien Ltd's Mallinckrodt unit, and Glenmark Pharmaceuticals--must stop manufacturing the unapproved...
Read moreIt has been about ten years since the United States Drug Enforcement Administration (DEA) launched what some feel is a targeted war on... Read more »
So, what is a doctor to do about the abuse of pain-killers? If doctors begin to act like police officers, then the doctor-patient... Read more »
Chronic pain patients (sometimes including Migraine sufferers) are often asked to sign narcotics contracts, or treatment agreements, with... Read more »
According to Canadian researchers, the number of deaths from opioid painkiller use has doubled since 1991, and they say the increased use and abuse... Read more »
Earlier this year, the U.S. Food and Drug Administration (FDA) presented the Risk Evaluation and Mitigation Strategy (REMS), a proposal designed to... Read more »
According to researchers at the University of Michigan, one in 10 high school seniors have used narcotic painkillers, though most of them use the... Read more »
Migraineurs and other chronic pain patients who use narcotics (opioids) are often asked to sign narcotics contracts, or treatment agreements, with... Read more »
People who take narcotic painkillers such as oxycodone and codeine too often to treat their migraines may be doubling their chances of having chronic... Read more »